Political Quotes

Anna Eshoo: I am so pleased, I am really very excited, that the House is considering this evening H.R. 3580, legislation which I…

On the recordOctober 7, 2002
I am so pleased, I am really very excited, that the House is considering this evening H.R. 3580, legislation which I introduced with my wonderful colleague, the gentleman from Pennsylvania (Mr. Greenwood), and worked with so many others on. It has been over a long period of time, not a short period of time, so I think that is why we are very excited that we have finally made it to the floor in the culmination of our work. It is a bipartisan bill, and it really is ultimately about patients, patients in our country, about making sure that patients are able to safely benefit from the wonders of medical technology in a very timely manner. As medical technologies have become more advanced, it takes more government resources to ensure that these products are safe and effective. That falls to a Federal agency, and that is the Food and Drug Administration. They regulate medical devices, and they have been overwhelmed by the volume of new products that they must review. So, number one, under this bill, and for the very first time in the history of our country, the medical device industry has agreed and will pay fees to the FDA for every product they propose to market.
Said by
Anna Eshoo
Democratic · California

Editor's note · Context

Discussing H.R. 3580, a bipartisan bill related to medical device regulation and patient safety.

Share

More from Anna Eshoo

Jun 20, 2023

I want to ask you if you will consider STAs and if you will commit to providing the public transparency that is really due because this is a huge issue?

congress.gov
Jun 20, 2023

It is stunning to me that someone pays for something, they don't get it, but the person or the entity they paid it to still gets to keep it.

congress.gov
Apr 18, 2023

Thank you for holding the hearing, and I yield back.

congress.gov
Apr 25, 2023

The PBM Accountability Act will finally shed a light on the opaque drug pricing system.

congress.gov

Other voices in this conversation